Final overall survival (OS) results of befotertinib in patients with pretreated EGFR T790M-positive locally advanced or metastatic non-small cell lung cancer (NSCLC) S. Lu, Y. Zhang,G. Zhang, J. Zhou, S. Cang,Y. Cheng, G. Wu,P. Cao, D. Lv, H. Jian,C. Chen, X. Jin, P. Tian, K. Wang, G. Jiang, G. Chen, Q. Chen,H. Zhao, C. Ding, L. DingANNALS OF ONCOLOGY（2023）引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
